Publications by authors named "Brandon Luber"

Claim this Profile
R
Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma.
Swetha Kambhampati Thiruvengadam, Alan H Tieu, Brandon Luber, Hao Wang, Stephen J Meltzer

Sci Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy.
Nicolas J Llosa, Brandon Luber, Nicholas Siegel, Anas H Awan, Teniola Oke

Cancer Immunol Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors.
Nicolas J Llosa, Brandon Luber, Ada J Tam, Kellie N Smith, Nicholas Siegel

Clin Cancer Res· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, Nicholas Siegel, Hongni Fan, Brandon S Luber

J Immunother Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.
Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, Nicholas Siegel, Hongni Fan, Brandon S Luber

J Immunother Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.
Steven P Rowe, Brandon Luber, Monique Makell, Patricia Brothers, JoAnn Santmyer

Mol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Chao Liang, Hao Wang

Eur Urol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
Karim Boudadi, Daniel L Suzman, Valsamo Anagnostou, Wei Fu, Brandon Luber

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Benjamin A Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149-56. AR-V7 Testing: What's in it for the Patient?: Estimating the Clinical Utility of Blood-based AR-V7 Testing in Prostate Cancer.
Jun Luo, Brandon Luber, Hao Wang, Emmanuel S Antonarakis

Eur Urol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.
Nicolas J Llosa, Kenneth R Cooke, Allen R Chen, Christopher J Gamper, Orly R Klein, Brandon Luber

Biol Blood Marrow Transplant· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Cancer Treatment Response by F-FDG PET/CT: Multicenter Assessment of Measurement Variability.
Joo Hyun O, Heather Jacene, Brandon Luber, Hao Wang, Minh-Huy Huynh

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen

J Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Brandon S Luber

Science· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.
Benjamin L Maughan, Brandon Luber, Rosa Nadal, Emmanuel S Antonarakis

Prostate· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria.
Andrew J Gunn, Rahul A Sheth, Brandon Luber, Minh-Huy Huynh, Niranjan R Rachamreddy

Cardiovasc Intervent Radiol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.
Benjamin L Maughan, Daniel L Suzman, Brandon Luber, Hao Wang, Stephanie Glavaris

Cancer Chemother Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group sequential designs with prospectively planned rules for subpopulation enrichment.
Michael Rosenblum, Brandon Luber, Richard E Thompson, Daniel Hanley

Stat Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Michael T Schweizer, Hao Wang, Brandon Luber, Rosa Nadal, Avery Spitz

Prostate· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.
Joo Hyun O, Brandon S Luber, Jeffrey P Leal, Hao Wang, Vanessa Bolejack

J Nucl Med· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.
Kaitlyn Sadtler, Kenneth Estrellas, Brian W Allen, Matthew T Wolf, Hongni Fan, Brandon S Luber

Science· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.
Jingya Wang, Amol K Narang, Elizabeth A Sugar, Brandon Luber, Lauren M Rosati

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Hao Wang, Yan Chen

JAMA Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.
Evan J Lipson, William H Sharfman, Shuming Chen, Tracee L McMiller, Theresa S Pritchard, Brandon Luber

J Transl Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Brandon S Luber

N Engl J Med· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis